Author(s)

Anju Majeed¹, Shaheen Majeed², Thontadarya Shivakumar³, Satish Gudimallam⁴, Kadlajji Parameshwarappa Avinash⁴, Vasantha Nagaraju⁴, Lakshmi Mundkur^5*

¹Department of Pharmacology, Sami-Sabinsa Group Limited, Bangalore, India.
²Department of Pharmacology, Sabinsa Corporation, East Windsor, USA.
³General Medicine, TR Super Speciality Hospital, Bengaluru, India.
⁴Clinical Research, Sami-Sabinsa Group Limited, Bangalore, India.
⁵Biological Research & Development, Sami-Sabinsa Group Limited, Bangalore, India.

Background: Bioenhancers augment the bioavailability of co-administered molecules without showing any significant effect on their own. Piperine, an alkaloid from Piper nigrum, is an established natural bioenhancer. Nicotinamide mononucleotide (NMN), an antiaging supplement, is the precursor of coenzyme nicotinamide adenine dinucleotide (NAD) that plays an important role in intracellular redox reactions. Objective: The study compared the serum concentrations of NAD in normal healthy participants, supplemented with NMN 500 mg and NMN 500 mg + 5 mg BioPerine^® (95% piperine). Methods: In a randomized, open-label, crossover study, NMN (500 mg) was compared to NMN + BioPerine^® (500 mg + 5 mg) in 6 healthy adults, aged 18 - 45 years. The participants received a single oral dose of NMN or NMN + BioPerine^® capsules with 240 mL water, and blood samples were collected over 8hr. After a 4-day washout period, the same procedures were repeated as per the crossover design. Total NAD (NAD_total), including oxidized NAD (the oxidized) and its reduced form NADH, was measured in human serum samples. Results: The maximum concentration (C_max) of NAD in serum was higher with NMN + BioPerine^® (282 pmol/mL) compared to NMN (246 pmol/mL) alone. In the presence of BioPerine^®, the NAD concentrations reached 257 pmol/mL during the first 2 hr, whereas a comparable serum concentration (246 pmol/mL) was attained only after 6 hr in NMN alone. The AUC_0-8hr was 1738 pmol/mL/hr in NMN compared to 2004 pmol/mL/hr in NMN+ BioPerine^®. The time to reach peak concentration (t_1/2) was similar (6hr) in both groups. No clinically relevant adverse events (AE) were observed, and safety parameters remained within normal ranges in all the participants with both formulations. Conclusion: These results reveal that BioPerine^® can effectively increase the NAD concentrations in the serum following NMN supplementation in healthy volunteers. The present study was registered prospectively with the Clinical Trials Registry-India (CTRI/2023/11/059982).

Bioavailability, BioPerine^®, Nicotinamide Mononucleotide, Nicotinamide Adenine Dinucleotide, Bioenhancer

Majeed, A. , Majeed, S. , Shivakumar, T. , Gudimallam, S. , Avinash, K. , Nagaraju, V. and Mundkur, L. (2024) Oral Administration of Nicotinamide Mononucleotide with Bioenhancer BioPerine^® Increases the Serum Concentration of Nicotinamide Adenine Dinucleotide in Healthy Human Volunteers: A Pilot, Open-Label, Cross-Over Study. Advances in Bioscience and Biotechnology, 15, 573-589. doi: 10.4236/abb.2024.1510036.